Study Finds ADHD Prevalence Unchanged Amid Ongoing Medication Shortages

A recent study has determined that the prevalence of Attention Deficit Hyperactivity Disorder (ADHD) has not increased, despite ongoing shortages of medications used to treat the condition. The findings come amid heightened demand for ADHD drugs, which have faced supply chain challenges in recent months.

Researchers conducted an analysis to assess whether ADHD diagnoses have been rising, as some had speculated due to increased awareness and access to treatment. The study concluded that there is no evidence of a significant uptick in cases of the disorder. However, this clarification coincides with reports of persistent shortages affecting several ADHD medications, including stimulants commonly prescribed for managing symptoms. Pharmaceutical companies and healthcare providers continue to navigate these supply issues while addressing patient needs.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: June 6, 2025

Related posts:

Tuberculosis Outbreak Investigation at Kalamazoo Central High School, Michigan DrugPatentWatch Guide Highlights Complexities in CDMO Pricing for Pharmaceutical Companies Tjoapack Addresses Biopharma Packaging Needs Amid Growth in Biologic Therapies PDSA Cycle Implementation in Retail Pharmacies Leads to Increased Administration of 20-Valent Pneumococcal Vaccine

Author

Mark Chiang